Same Day ShippingFREE Shipping Over $99Satisfaction GuaranteedSame Day ShippingFREE Shipping Over $99Satisfaction GuaranteedSame Day ShippingFREE Shipping Over $99Satisfaction GuaranteedSame Day ShippingFREE Shipping Over $99Satisfaction Guaranteed
HomeProductsRetatrutide
Retatrutide
Metabolic Research

Retatrutide

$149.99In Stock

Retatrutide is a triple agonist research peptide targeting GLP-1, GIP, and glucagon receptors. This novel compound is studied in metabolic research applications.

Purity

99%+

Size

15mg

1
COA Available
Lab Verified
Fast Shipping

Specifications

AppearanceWhite lyophilized powder
StorageStore at -20°C
SolubilitySoluble in sterile water

Certificate of Analysis

Each batch of Retatrutide undergoes rigorous third-party testing to ensure purity and identity verification. COA documentation is available upon request.

HPLC Purity Analysis
Mass Spectrometry Verification
Lot-Specific Documentation

Extended Research Applications & Mechanisms

Scientific Profile

Retatrutide is a novel triple agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. This multi-receptor approach represents a new frontier in metabolic research with unprecedented effects on energy metabolism.

Mechanisms of Action

1

GLP-1 Receptor Agonism - Enhances insulin secretion, reduces appetite

2

GIP Receptor Agonism - Potentiates incretin effects

3

Glucagon Receptor Agonism - Increases energy expenditure

4

Triple Agonism - Synergistic metabolic effects

Research Applications

1Obesity & Weight Research

Primary research focus on weight and body composition.

Key Research Findings
  • Demonstrates significant weight reduction in models
  • Reduces food intake through central appetite regulation
  • Increases energy expenditure via glucagon activity
  • Superior efficacy compared to single/dual agonists

2Glucose Homeostasis

Research on glycemic control and diabetes models.

Key Research Findings
  • Improves glycemic control significantly
  • Enhances beta-cell function
  • Reduces HbA1c in diabetic models
  • Improves insulin sensitivity

3Liver & Metabolic Health

Studies on hepatic and metabolic parameters.

Key Research Findings
  • Reduces hepatic steatosis (fatty liver)
  • Improves liver enzyme profiles
  • Reduces triglycerides and cholesterol
  • Potential NAFLD/NASH research applications

Supporting Research & Bibliography

The following peer-reviewed publications support the research applications described above. References are provided for informational purposes to assist researchers in their literature review.

1

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes

Rosenstock J, Frias J, Jastreboff AM, et al.

Lancet2023;402:529-544DOIPubMed
2

Triple-hormone-receptor agonist retatrutide for obesity

Jastreboff AM, Kaplan LM, Frias JP, et al.

New England Journal of Medicine2023;389:514-526DOIPubMed
3

LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss

Coskun T, Urva S, Roell WC, et al.

Cell Metabolism2022;34:1234-1247DOIPubMed

Total references: 3

Note: The information provided is for research reference only. All research applications are based on in-vitro and animal studies. This product is intended for laboratory research purposes only. Not for human or veterinary use.

Research Use Only: This product is intended for laboratory research purposes only. Not for human or veterinary use. By purchasing, you confirm that you are a qualified researcher and will use this product in accordance with all applicable regulations.